Another Philadelphia jury has decided that drugmaker Wyeth should be punished with punitive damages for the warnings provided to a plaintiff and her doctor over the risk of breast cancer from Wyeth’s hormonal drug Prempro.
The jury awarded $6 million in punitive damages and $3.45 million in compensatory damages Monday in Singleton v. Wyeth. According to plaintiffs’ counsel Zoe Littlepage of Littlepage Booth in Houston, this case is the first in the country involving a plaintiff diagnosed with breast cancer well after the July 2002 release of the Women’s Health Initiative, a randomized, controlled trial of the risks and benefits of hormone replacement.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]